Clinical TrialsSearch results
Number of results: 612
Recruiting
- Living donor liver transplantation for non-resectable colorectal liver metastases
- non-resectable colorectal liver metastases
- Hatano Etsuro
- 2023-06-25
Recruiting
- Phase II Clinical Trial of Preoperative Chemoradiotherapy for Resectable Pancreatic Cancer
- Pancreatic cancer
- Hatano Etsuro
- 2024-09-04
Recruiting
- RACB Study
- Hepatocellular Carcinoma
- Hatano Etsuro
- 2022-01-07
Recruiting
- A Phase 1, Open-label, Dose Finding Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Subjects with Relapsed and Refractory Multiple Myeloma
- Relapsed and refractory multiple myeloma
- Hayakawa Jin
- 2023-10-04
Completed
- A clinical trial of dried allogeneic cultured epidermis (Allo-JaCE03) for deep dermal burn
- deep dermal burn (DDB)
- Hayashi Shigeaki
- 2022-03-31
Other
- A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning
- Chronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphoma
- Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare
- 2005-10-01
Other
- A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma.
- Mantle cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2008-10-11
Other
- A phase2 study of Rituximab+THP-COP(R-THP-COP) in elderly subjects with untreated, advanced, CD20-positive, indolent B-cell Non-Hodgkin's lymphoma
- indolent B-cell lymphoma
- Hematological Malignancy Clinical Study Group
- 2009-08-03
Not yet recruiting
- A Phase I, Multicentre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination With Radiation Therapy in Patients With Glioblastoma Multiforme and Brain Metastases From Solid Tumors.
- Recurrent Glioblastoma Multiforme
- Hibi Kazushige
- 2024-09-02
Other
- The High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study
- hypertension, dyslipidemia, glucose intolerance and smoking
- HIPOP-OHP Study Research group
- 2005-09-12